Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study of the Efficacy and Safety of Aspirin Therapy With CABG

NCT02942680 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT02942680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02942680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study of the Efficacy and Safety of Aspirin Therapy With CABG
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease